FCOMV
Foresite Capital Opportunity Management V Portfolio holdings
AUM
$33.3M
1-Year Return
46.98%
This Quarter Return
-10.8%
1 Year Return
-46.98%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$33.3M
AUM Growth
-$6.37M
(-16%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 94.87% |
| 2 | Consumer Staples | 5.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| $9.67M | 29.04% |
5,227,307
| – | – |
|
|
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $5.56M | 16.71% |
959,275
| – | – |
|
3
Disc Medicine
IRON
$2.08B
| $3.99M | 11.99% |
81,171
| – | – |
|
4
Compass Therapeutics
CMPX
$613M
| $3.54M | 10.64% |
1,554,250
| – | – |
|
|
KNTE
5
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $3.49M | 10.46% |
291,667
| – | – |
|
6
Adicet Bio
ACET
$67.5M
| $2.42M | 7.26% |
170,000
| – | – |
|
7
Quantum-Si Incorporated
QSI
$239M
| $1.74M | 5.23% |
633,626
| – | – |
|
8
Hims & Hers Health
HIMS
$12.5B
| $1.71M | 5.13% |
306,431
| – | – |
|
9
Enanta Pharmaceuticals
ENTA
$177M
| $1.18M | 3.54% |
22,750
| – | – |
|